Thursday May 25th 2017

‘People’ Archives

VIDEO: Being treated for MS led to a marriage proposal for couple

VIDEO: Being treated for MS led to a marriage proposal for couple

Last month, Rusty Parsons walked into the Mellen Center at the Cleveland Clinic, the same place he has sat through numerous doctors appointments in his battle with multiple sclerosis, and faced his biggest challenge. Sitting in a chair across the room was the love of his [Read More]

Forced to seek MS treatment in U.S

Forced to seek MS treatment in U.S

We just had the most amazing and successful fundraiser at the Fogolar Furlan for my husband, Barry Ashby. He suffers with multiple sclerosis (MS), has narrowed neck veins and goes to California on March 22 for the “Liberation Therapy” (CCSVI), unfortunately, not [Read More]

Fundraiser set to help MS sufferer

Fundraiser set to help MS sufferer

A group of young people have teamed up with local businesses to help a Riverview woman suffering from multiple sclerosis make the trip to the United States for a life-altering medical procedure. The group has launched the “Save-a-mom” fundraising campaign to [Read More]

 Page 1 of 21  1  2  3  4  5 » ...  Last » 

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]